Luke Kuttschreuter

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Gianantonio Rosti, Tim Henrik Brümmendorf, Björn T Gjertsen, Pilar Giraldo-Castellano, Fausto Castagnetti, Carlo B Gambacorti-Passerini, Thomas Ernst, Huadong Zhao, Luke Kuttschreuter, Simon Purcell, Francis J Giles, Andreas Hochhaus
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study. Leukemia (2023)
Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang, Harm D R van Tinteren, Vincent H J van der Velden, H Berna Beverloo, Monique L Den Boer, Lukas A J Rammeloo, Chad Hudson, Nyla Heerema, Karey Kowalski, Huadong Zhao, Luke Kuttschreuter, Francisco J Bautista Sirvent, Andrew Bukowinski, Carmelo Rizzari, Jessica A Pollard, Laura Murillo, Matthew Kutny, Sara Zarnegar, Michele S Redell, Stacy Cooper, Yves Bertrand, Arnaud Petit, Julie I Krystal, Markus Metzler, Donna Lancaster, Jean-Pierre Bourquin, Jayashree Motwani, Inge M Van der Sluis, Franco Locatelli, Michael E Roth, Nobuko Hijiya, Christian Michel Zwaan
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)